知搜-全球专利检索

  1. 登录
  2. 注册

搜索结果

21 条记录 (耗时 0.015 秒)

    Benzylideneguanidine Derivatives and Therapeutic Use for the Treatment of Protein Misfolding Diseases
    1.
    发明申请
    Benzylideneguanidine Derivatives and Therapeutic Use for the Treatment of Protein Misfolding Diseases 有权
    亚苄基胍衍生物和治疗用于治疗蛋白质错折叠疾病的治疗用途

    公开(公告)号：US20160046589A1

    公开(公告)日：2016-02-18

    申请号：US14760350

    申请日：2014-01-10

    申请人： Philippe GUEDAT ,  MEDICAL RESEARCH COUNCIL

    发明人： Philippe Guedat ,  Anne Bertolotti

    IPC分类号： C07D253/075 ,  C07C281/16 ,  A61K31/165 ,  A61K31/216 ,  A61K31/44 ,  C07D213/61 ,  A61K31/155 ,  A61K31/53

    CPC分类号： C07D253/075 ,  A61K31/155 ,  A61K31/165 ,  A61K31/216 ,  A61K31/44 ,  A61K31/53 ,  A61K45/06 ,  C07C281/16 ,  C07C281/18 ,  C07D213/61 ,  A61K2300/00

    摘要： The present invention relates to a compound of formula (I), or a tautomer and/or a pharmaceutically acceptable salt thereof, wherein: R1 is alkyl, Cl, F or Br; R2 is H or F; R3 is selected from H and alkyl; R4 is selected from H and C(O)R6; R5 is H; or R4 and R5 are linked to form a heterocyclic group which is optionally substituted with one or more R10 groups; R6 is selected from R7, OR7 and NR8R9; R7, R8 and R9 are each independently selected from alkyl, cycloalkyl, aralkyl, cycloalkenyl, heterocyclyl and aryl, each of which is optionally substituted with one or more R10 groups; each R10 is independently selected from halogen, OH, CN, NO2, COO-alkyl, aralkyl, SO2-alkyl, SO2-aryl, COOH, CO-alkyl, CO-aryl, NH2, NH-alkyl, N(alkyl)2, CF3, alkyl and alkoxy; X and Z are each independently CR11, and Y is selected from CR11 and N; and R11 is H or F; for use in treating a disorder associated with protein misfolding stress and in particular associated with accumulation of misfolded proteins.

    摘要翻译： 本发明涉及式（I）化合物或其互变异构体和/或其药学上可接受的盐，其中：R 1是烷基，Cl，F或Br; R2为H或F; R3选自H和烷基; R 4选自H和C（O）R 6; R5是H; 或R 4和R 5连接形成任选被一个或多个R 10基取代的杂环基; R6选自R7，OR7和NR8R9; R 7，R 8和R 9各自独立地选自烷基，环烷基，芳烷基，环烯基，杂环基和芳基，其各自任选被一个或多个R 10基团取代; 每个R 10独立地选自卤素，OH，CN，NO 2，COO-烷基，芳烷基，SO 2 - 烷基，SO 2 - 芳基，COOH，CO-烷基，CO-芳基，NH 2，NH-烷基，N（烷基） CF 3，烷基和烷氧基; X和Z各自独立地为CR11，Y选自CR11和N; R11为H或F; 用于治疗与蛋白质错误折叠应激相关的病症，特别是与错误折叠的蛋白质的积累相关。

    THIAZOLYLIMIDAZOLE DERIVATIVES AN THEIR USE AS INHIBITORS OF MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN
    2.
    发明申请
    THIAZOLYLIMIDAZOLE DERIVATIVES AN THEIR USE AS INHIBITORS OF MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN 审中-公开
    它们作为微量TRIGLYCERIDE转移蛋白的抑制剂使用的三唑基咪唑衍生物

    公开(公告)号：US20100137601A1

    公开(公告)日：2010-06-03

    申请号：US12700441

    申请日：2010-02-04

    申请人： Philippe GUEDAT ,  Olivier Chevreuil ,  Thierry Convard

    发明人： Philippe GUEDAT ,  Olivier Chevreuil ,  Thierry Convard

    IPC分类号： C07D401/14

    CPC分类号： C07D417/14

    摘要： The present invention relates to thiazolylimidazole derivatives of the general formula (I) in which: G represents a bond or a divalent radical chosen from the groups g1, g2 and g3; and R1, R2, R3, R4, R5, R6, Y and Z are as defined in the description. Application of the compounds of the formula (I) to the treatment of hypertriglyceridaemia, hypercholesterolaemia and dyslipidaemia.

    摘要翻译： 本发明涉及通式（I）的噻唑咪唑衍生物，其中：G表示选自基团g1，g2和g3的键或二价基团; 并且R1，R2，R3，R4，R5，R6，Y和Z如说明书中所定义。 式（I）化合物用于治疗高甘油三酯血症，高胆固醇血症和血脂异常。